Literature DB >> 7685330

Target epitopes of myelin basic protein specific T cell lines in multiple sclerosis.

G Ristori1, M Salvetti, C Buttinelli, M Falcone, S Trabace, C Fieschi.   

Abstract

A highly efficient new method for the generation of antigen specific T cell lines (TCL) is now available. By this method we established 134 myelin basic protein (MBP) TCL from the peripheral blood of 9 patients with definite multiple sclerosis (n = 69) and 8 healthy donors (n = 65). The yield of MBP reactive TCL in the two groups was comparable. So far 22 MBP specific TCL from 7 patients and 24 from 7 healthy individuals have been tested for their proliferative response to a panel of four synthetic peptides representing MBP residues 7-26, 80-99, 139-153 and 148-162. Although the peptide sequences did not encompass the whole MBP, the pattern of reactivity to these peptides in patients and controls seems to be similar. Further, when multiple TCL from the same donor were analysed, no dominant recognition emerged.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685330     DOI: 10.1007/bf02335748

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  12 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  T cells responsive to myelin basic protein in patients with multiple sclerosis.

Authors:  M Allegretta; J A Nicklas; S Sriram; R J Albertini
Journal:  Science       Date:  1990-02-09       Impact factor: 47.728

3.  Myelin basic proteins.

Authors:  E H Eylar; P J Kniskern; J J Jackson
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

Review 4.  MS: a CNS and systemic autoimmune disease.

Authors:  D A Hafler; H L Weiner
Journal:  Immunol Today       Date:  1989-03

5.  T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.

Authors:  K Ota; M Matsui; E L Milford; G A Mackin; H L Weiner; D A Hafler
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

6.  Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.

Authors:  R Martin; D Jaraquemada; M Flerlage; J Richert; J Whitaker; E O Long; D E McFarlin; H F McFarland
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

7.  Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.

Authors:  T Olsson; W W Zhi; B Höjeberg; V Kostulas; Y P Jiang; G Anderson; H P Ekre; H Link
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

8.  Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein.

Authors:  K W Wucherpfennig; K Ota; N Endo; J G Seidman; A Rosenzweig; H L Weiner; D A Hafler
Journal:  Science       Date:  1990-05-25       Impact factor: 47.728

9.  Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.

Authors:  M Pette; K Fujita; D Wilkinson; D M Altmann; J Trowsdale; G Giegerich; A Hinkkanen; J T Epplen; L Kappos; H Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

10.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.

Authors:  C Confavreux; G Aimard; M Devic
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.